Leukemia & Lymphoma, Volume 51, Issue 9 (2010)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 51, Issue 9 (2010)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Volume 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Letters to the Editor

Letter
Rituximab–lenalidomide–dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma
Vadim Ivanov, Emeline Tabouret, Guillaume Chuto, Bruno Chetaille, Hacène Fezoui, Diane Coso, Jerome Rey, Therese Aurran-Schleinitz, Jean Marc Schiano, Anne Marie Stoppa, Didier Blaise & Reda Bouabdallah
Pages: 1-3
Published online: 14 Jul 2010
First Page PreviewforRituximab–lenalidomide–dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma | Full Text | References | PDF (423.7 KB)
  • 571 Views
  • 14 CrossRef citations
  • 0Altmetric
Letter
Successful management of pregnancy occurring in a patient with chronic myeloid leukemia on dasatinib
Tara Kroll, Mary B. Ames, Julie A. Pruett & Timothy S. Fenske
Pages: 1-3
Published online: 14 Jul 2010
First Page PreviewforSuccessful management of pregnancy occurring in a patient with chronic myeloid leukemia on dasatinib | Full Text | References | PDF (137.4 KB)
  • 311 Views
  • 28 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission
Lisa Sproat, Brian Bolwell, Lisa Rybicki, Shawnda Tench, Josephine Chan, Matt Kalaycio, Robert Dean, Ronald Sobecks, Brad Pohlman, Steven Andresen, John Sweetenham & Edward Copelan
Pages: 1-6
Published online: 14 Jul 2010
AbstractforEffect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission | Full Text | References | PDF (160.7 KB)
  • 87 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study
Mariano Provencio, Clara Salas, Isabel Millán, Blanca Cantos, Antonio Sánchez & Carmen Bellas
Pages: 1-6
Published online: 14 Jul 2010
AbstractforLate relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study | Full Text | References | PDF (199.2 KB)
  • 303 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Jean El-Cheikh, Luca Castagna, Ling Wang, Benjamin Esterni, Catherine Faucher, Sabine Fürst, Berger Pierre, Mohamad Mohty & Didier Blaise
Pages: 1-6
Published online: 14 Jul 2010
AbstractforImpact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant | Full Text | References | PDF (280.3 KB)
  • 235 Views
  • 15 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2–V617F mutational status
Jacek Treliński, Agnieszka Wierzbowska, Anna Krawczyńska, Agata Sakowicz, Tadeusz Pietrucha, Piotr Smolewski, Tadeusz Robak & Krzysztof Chojnowski
Pages: 1-7
Published online: 08 Jul 2010
AbstractforPlasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2–V617F mutational status | Full Text | References | PDF (361.9 KB)
  • 151 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML–RARα negative human myeloblastic leukemia cells
Satyaprakash Nayak, Miaoqing Shen, Rodica P. Bunaciu, Stephen E. Bloom, Jeffrey D. Varner & Andrew Yen
Pages: 1-14
Published online: 08 Jul 2010
AbstractforArsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML–RARα negative human myeloblastic leukemia cells | Full Text | References | PDF (1.9 MB)
  • 197 Views
  • 11 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone
David Hui, Bradley Proctor, Jane Donaldson, Tamara Shenkier, Paul Hoskins, Richard Klasa, Kerry Savage, Mukesh Chhanabhai, Randy D. Gascoyne, Joseph M. Connors & Laurie H. Sehn
Pages: 1-10
Published online: 26 Aug 2010
AbstractforPrognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone | Full Text | References | PDF (660 KB)
  • 436 Views
  • 37 CrossRef citations
  • 0Altmetric

Commentary

Article Commentary
Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma
Kieron Dunleavy & Wyndham H. Wilson
Pages: 1-2
Published online: 26 Aug 2010
CitationforTargeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma | Full Text | References | PDF (130.6 KB)
  • 683 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Individualizing cancer therapy
Morie A. Gertz & Tamar Tadmor
Pages: 1585-1587
Published online: 25 Jun 2010
First Page PreviewforIndividualizing cancer therapy | Full Text | References | PDF (138.5 KB)
  • 348 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Prognostic markers in diffuse large B-cell lymphoma
Jan Delabie
Pages: 1588-1589
Published online: 31 Aug 2010
CitationforPrognostic markers in diffuse large B-cell lymphoma | Full Text | References | PDF (131.1 KB)
  • 371 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Obesity and lymphoma therapy: not a bad combination after all
Willis H. Navarro & Fausto R. Loberiza
Pages: 1590-1591
Published online: 31 Aug 2010
CitationforObesity and lymphoma therapy: not a bad combination after all | Full Text | References | PDF (131.7 KB)
  • 344 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge
Philip A. Thompson, Constantine S. Tam, Karin Thursky & John F. Seymour
Pages: 1592-1595
Published online: 31 Aug 2010
First Page PreviewforHepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge | Full Text | References | PDF (148 KB)
  • 564 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
New angles of attack in the fight against chronic lymphocytic leukemia: the advent of novel non-chemotherapeutic agents
Ali Bazargan & Constantine S. Tam
Pages: 1596-1611
Published online: 25 Jun 2010
AbstractforNew angles of attack in the fight against chronic lymphocytic leukemia: the advent of novel non-chemotherapeutic agents | Full Text | References | PDF (235.4 KB)
  • 94 Views
  • 3 CrossRef citations
  • 0Altmetric
Review Article
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference
Martin Dreyling, Eva Hoster, Silvia Bea, Elena Hartmann, Heike Horn, Grit Hutter, Itziar Salaverria, Christiane Pott, Marek Trneny, Steven Le Gouill, Sergio Cortelazzo, Michal Szymczyk, Wojciech Jurczak, Ofer Shpilberg, Vincent Ribrag, Olivier Hermine, For The European Mcl Network & For The European Mcl Network
Pages: 1612-1622
Published online: 14 Jul 2010
AbstractforUpdate on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference | Full Text | References | PDF (1.2 MB)
  • 352 Views
  • 20 CrossRef citations
  • 0Altmetric
Review Article
Approaches to the early treatment of invasive fungal infection
James I. Ito, Jane Kriengkauykiat, Sanjeet S. Dadwal, Lisa M. Arfons & Hillard M. Lazarus
Pages: 1623-1631
Published online: 14 Jul 2010
AbstractforApproaches to the early treatment of invasive fungal infection | Full Text | References | PDF (286.9 KB)
  • 281 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcome
Ba Thanh-Truc Ngo, Julia Felthaus, Manuel Hein, Marie Follo, Dagmar Wider, Gabriele Ihorst, Monika Engelhardt & Ralph Wäsch
Pages: 1632-1642
Published online: 25 Jun 2010
AbstractforMonitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcome | Full Text | References | PDF (1.1 MB) | Supplemental
  • 231 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Karin Rydström, Johan Linderoth, Heidi Nyman, Mats Ehinger, Patrick Joost, Pär-Ola Bendahl, Sirpa Leppä & Mats Jerkeman
Pages: 1643-1648
Published online: 01 Jul 2010
AbstractforCD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy | Full Text | References | PDF (444.4 KB)
  • 127 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma
Jeffrey A. Jones, Luis E. Fayad, Linda S. Elting & Maria A. Rodriguez
Pages: 1649-1657
Published online: 31 Aug 2010
AbstractforBody mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma | Full Text | References | PDF (339.5 KB)
  • 294 Views
  • 38 CrossRef citations
  • 0Altmetric
Article
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low–intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol
Pierre Morel, Jean-Nicolas Munck, Bertrand Coiffier, Christian Gisselbrecht, Dana Ranta, Andre Bosly, Hervé Tilly, Bruno Quesnel, Antoine Thyss, Nicolas Mounier, Josette Brière, Thierry Molina, Felix Reyes & FOR THE GROUPE D'ETUDE DES LYMPHOMES DE L'ADULTE (GELA)
Pages: 1668-1677
Published online: 31 Aug 2010
AbstractforComparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low–intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol | Full Text | References | PDF (417.8 KB)
  • 319 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma
Xing Li, Qu Lin, Min Dong, Jing-Yun Wen, Li Wei, Xiao-Kun Ma, Zhan-Hong Chen & Xiang-Yuan Wu
Pages: 1678-1685
Published online: 31 Aug 2010
AbstractforPrognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma | Full Text | References | PDF (330.6 KB) | Supplemental
  • 147 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma
Yan-Yan Liu, Shu-Na Yao, Yan Zhao, Zhi-Hua Yao, Jie MA, Qing-Xin Xia, Kai Fu & Shu-Jun Yang
Pages: 1692-1698
Published online: 31 Aug 2010
AbstractforPTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma | Full Text | References | PDF (611.3 KB)
  • 261 Views
  • 11 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
Elizabeth A. Griffiths, Steven D. Gore, Craig Hooker, Michael A. McDevitt, Judith E. Karp, B. Douglas Smith, Helai P. Mohammad, Ying Ye, James G. Herman & Hetty E. Carraway
Pages: 1711-1719
Published online: 26 Aug 2010
AbstractforAcute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation | Full Text | References | PDF (532.2 KB) | Supplemental
  • 495 Views
  • 59 CrossRef citations
  • 0Altmetric
Article
Quantification of PDGFRA alternative transcripts improves the screening for X–PDGFRA fusions by reverse transcriptase-polymerase chain reaction
Ignacio Erquiaga, Cristina Ormazábal, Cristina Hurtado, Paula Aranaz, María J. Calasanz, Marina García-Delgado, Francisco J. Novo & José L. Vizmanos
Pages: 1720-1726
Published online: 08 Jul 2010
AbstractforQuantification of PDGFRA alternative transcripts improves the screening for X–PDGFRA fusions by reverse transcriptase-polymerase chain reaction | Full Text | References | PDF (273.2 KB) | Supplemental
  • 92 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Coexistence of different types of biallelic immunoglobulin heavy variable gene replacement events in a case of pediatric B precursor acute lymphoblastic leukemia
Anastasia Hadzidimitriou, Nikos Darzentas, Anna Karakoli, Dimitrios Koliouskas, Athanasios Tsaftaris, Achilles Anagnostopoulos & Kostas Stamatopoulos
Pages: 1748-1750
Published online: 25 Jun 2010
First Page PreviewforCoexistence of different types of biallelic immunoglobulin heavy variable gene replacement events in a case of pediatric B precursor acute lymphoblastic leukemia | Full Text | References | PDF (308.6 KB)
  • 27 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Addressing uncertainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma
Rohit P. Ojha, Lindsey M. Brown, Martha J. Felini, Karan P. Singh & Raymond Thertulien
Pages: 1754-1757
Published online: 14 Jul 2010
First Page PreviewforAddressing uncertainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma | Full Text | References | PDF (145.5 KB)
  • 58 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders
Francesca Montanari, Govind Bhagat, Sean Clark-Garvey, Venkatraman Seshan, Jasmine Zain, Catherine Diefenbach, Erin Mccormick, Meaghan Crook, Meghan Conroy & Owen A. O'connor
Pages: 1761-1764
Published online: 31 Aug 2010
First Page PreviewforMonomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders | Full Text | References | PDF (425.2 KB)
  • 127 Views
  • 8 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles